目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Drug
Market segments
Comparison by Drug
Sapropterin - Market size and forecast 2021-2026
Pegvaliase-pqpz - Market size and forecast 2021-2026
Market opportunity by Drug

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
Asia - Market size and forecast 2021-2026
ROW - Market size and forecast 2021-2026
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
American Gene Technologies
BioMarin Pharmaceutical Inc.
Codexis Inc.
Evox Therapeutics Ltd.
Homology Medicines Inc.
Jnana Therapeutics
SOM INNOVATION BIOTECH SA
Synlogic Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ($ million)
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Drug - Market share 2021-2026 (%)
22: Comparison by Drug
23: Sapropterin - Market size and forecast 2021-2026 ($ million)
24: Sapropterin - Year-over-year growth 2021-2026 (%)
25: Pegvaliase-pqpz - Market size and forecast 2021-2026 ($ million)
26: Pegvaliase-pqpz - Year-over-year growth 2021-2026 (%)
27: Market opportunity by Drug
28: Customer landscape
29: Market share By Geographical Landscape 2021-2026 (%)
30: Geographic comparison
31: North America - Market size and forecast 2021-2026 ($ million)
32: North America - Year-over-year growth 2021-2026 (%)
33: Europe - Market size and forecast 2021-2026 ($ million)
34: Europe - Year-over-year growth 2021-2026 (%)
35: Asia - Market size and forecast 2021-2026 ($ million)
36: Asia - Year-over-year growth 2021-2026 (%)
37: ROW - Market size and forecast 2021-2026 ($ million)
38: ROW - Year-over-year growth 2021-2026 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: American Gene Technologies - Overview
48: American Gene Technologies - Product and service
49: American Gene Technologies - Key offerings
50: American Gene Technologies - Key customers
51: American Gene Technologies - Segment focus
52: BioMarin Pharmaceutical Inc. - Overview
53: BioMarin Pharmaceutical Inc. - Product and service
54: BioMarin Pharmaceutical Inc. - Key offerings
55: BioMarin Pharmaceutical Inc. - Key customers
56: BioMarin Pharmaceutical Inc. - Segment focus
57: Codexis Inc. - Overview
58: Codexis Inc. - Business segments
59: Codexis Inc. - Key offerings
60: Codexis Inc. - Key customers
61: Codexis Inc. - Segment focus
62: Evox Therapeutics Ltd. - Overview
63: Evox Therapeutics Ltd. - Product and service
64: Evox Therapeutics Ltd. - Key offerings
65: Evox Therapeutics Ltd. - Key customers
66: Evox Therapeutics Ltd. - Segment focus
67: Homology Medicines Inc. - Overview
68: Homology Medicines Inc. - Product and service
69: Homology Medicines Inc. - Key offerings
70: Homology Medicines Inc. - Key customers
71: Homology Medicines Inc. - Segment focus
72: Jnana Therapeutics - Overview
73: Jnana Therapeutics - Product and service
74: Jnana Therapeutics - Key offerings
75: Jnana Therapeutics - Key customers
76: Jnana Therapeutics - Segment focus
77: SOM INNOVATION BIOTECH SA - Overview
78: SOM INNOVATION BIOTECH SA - Product and service
79: SOM INNOVATION BIOTECH SA - Key offerings
80: SOM INNOVATION BIOTECH SA - Key customers
81: SOM INNOVATION BIOTECH SA - Segment focus
82: Synlogic Inc. - Overview
83: Synlogic Inc. - Product and service
84: Synlogic Inc. - Key offerings
85: Synlogic Inc. - Key customers
86: Synlogic Inc. - Segment focus
87: Currency conversion rates for US$
88: Research Methodology
89: Validation techniques employed for market sizing
90: Information sources
91: List of abbreviations